MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies

[1]  Kimberly A. Thomas,et al.  Immune correlates of tuberculosis disease and risk translate across species , 2020, Science Translational Medicine.

[2]  M. Wadsworth,et al.  Prevention of tuberculosis in macaques after intravenous BCG immunization , 2020, Nature.

[3]  M. Tameris,et al.  Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial. , 2019, The Lancet. Respiratory medicine.

[4]  T. Ottenhoff,et al.  Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques , 2019, Nature Medicine.

[5]  F. Gleeson,et al.  Refinement and reduction through application of a quantitative score system for estimation of TB-induced disease burden using computed tomography , 2018, Laboratory animals.

[6]  Daniel E. Zak,et al.  Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine , 2018, Nature Medicine.

[7]  J. Gonzalo-Asensio,et al.  MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic , 2017, Front. Immunol..

[8]  M. Roederer,et al.  Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design , 2017, Infection and Immunity.

[9]  Mahavir Singh,et al.  Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis , 2017, Nature Communications.

[10]  F. Gleeson,et al.  Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations , 2016, Tuberculosis.

[11]  J. Badiola,et al.  MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice , 2016, Tuberculosis.

[12]  Fergus Gleeson,et al.  Route of delivery to the airway influences the distribution of pulmonary disease but not the outcome of Mycobacterium tuberculosis infection in rhesus macaques. , 2016, Tuberculosis.

[13]  Fergus Gleeson,et al.  Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques. , 2016, Tuberculosis.

[14]  B. Fischer.  Lessons Learned. , 2016, Schizophrenia bulletin.

[15]  F. Spertini,et al.  Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial. , 2015, The Lancet. Respiratory medicine.

[16]  A. Lackner,et al.  Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis , 2015, Nature Communications.

[17]  F. Gleeson,et al.  Early lesions following aerosol challenge of rhesus macaques (Macaca mulatta) with Mycobacterium tuberculosis (Erdman strain). , 2015, Journal of comparative pathology.

[18]  W. Ho,et al.  Monkey Models of Tuberculosis: Lessons Learned , 2014, Infection and Immunity.

[19]  J. Flynn,et al.  Modeling tuberculosis in nonhuman primates. , 2014, Cold Spring Harbor perspectives in medicine.

[20]  B. Gicquel,et al.  Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials. , 2013, Vaccine.

[21]  A. Lackner,et al.  The non‐human primate model of tuberculosis , 2012, Journal of medical primatology.

[22]  A. Williams,et al.  Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models , 2011, Journal of applied microbiology.

[23]  Adrian V. S. Hill,et al.  Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing , 2010, Clinical and Vaccine Immunology.

[24]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[25]  G. Colditz,et al.  Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  F. Mosteller,et al.  Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature , 1994 .

[27]  W. Busey,et al.  Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. , 2015, The American review of respiratory disease.

[28]  H. A. Druett.  A mobile form of the Henderson apparatus , 1969, Journal of Hygiene.

[29]  G. Harper,et al.  The respiratory retention of bacterial aerosols: experiments with radioactive spores , 1953, Journal of Hygiene.